Covestor Ltd - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$33
+6.5%
1,229
+21.9%
0.02%
+4.2%
Q2 2023$31
-68.4%
1,008
-63.0%
0.02%
-71.8%
Q1 2023$98
-37.2%
2,724
-30.7%
0.08%
+32.8%
Q4 2022$156
-99.8%
3,932
+107.1%
0.06%
-4.5%
Q3 2022$76,0001,899
+27028.6%
0.07%
Q2 2022$0
-100.0%
7
-46.2%
0.00%
-100.0%
Q1 2022$1,0000.0%13
-7.1%
0.00%0.0%
Q4 2021$1,000140.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders